What does the research actually show?
Evidence is useful when you know which animal was studied, which preparation was tested and how the outcome was measured.
Green-lipped mussel has been studied as powder in food, as extracts and as part of mixed-ingredient products. Those findings cannot all be applied to the same daily serving.
Mussel powder and enriched diets
Bierer & Bui — The Journal of Nutrition
Researchers compared green-lipped mussel supplied in different food formats to controls over six weeks. They reported improvements in veterinary arthritis scores in supplemented groups. These are results for the tested diets and powder, not evidence that all consumer supplements have the same effect.
Read the paper ↗ · PubMed record ↗Bui & Bierer — powder added to food
Thirty-one dogs with signs of arthritis were assigned to a control diet or the same diet with 0.3% green-lipped mussel powder for six weeks. Veterinary scores for overall arthritis, joint pain and swelling improved more in the mussel group; crepitus and range of movement did not differ significantly. This tested a complete diet, not a scoop of a retail powder on its own.
Read the trial ↗Servet, Biourge & Marniquet
In a field study, 85 dogs with osteoarthritis ate a green-lipped-mussel-enriched diet for 50 days. Veterinary assessments reported improved clinical signs. Without a concurrent placebo group, other factors could have contributed to the change.
Read the paper ↗Rialland and colleagues
Twenty-three dogs received a control diet first, then a mussel-enriched diet. Force-plate measures and some owner-reported outcomes improved after the mussel diet. Because the dogs were not in simultaneous randomized groups, time and other changes could have influenced the result.
Read the study ↗Mussel preparations and extracts
Pollard and colleagues — when might results appear?
Eighty-one dogs with mild-to-moderate degenerative joint disease received a green-lipped mussel extract or placebo for 56 days. Both groups improved from baseline by day 28, with no significant difference between them then. By day 56, a higher proportion of dogs receiving the extract had improved clinical signs than dogs receiving placebo. The musculoskeletal score comparison narrowly missed conventional statistical significance. A specific extract was tested; improvement in two weeks was not established by this trial.
Read the trial ↗Hielm-Björkman and colleagues
Forty-five dogs with diagnosed osteoarthritis completed a randomized trial comparing green-lipped mussel preparation, carprofen and placebo. Some pain assessments favoured mussel over placebo; it was less effective than carprofen. Small groups and different outcome measures limit what one can claim.
Read the study ↗Cave, Bolton & Cogger
In a blinded crossover pilot, 32 working farm dogs with musculoskeletal abnormalities were recruited and 27 were analysed. Dogs received either 180 or 220 mg of a particular full-fat mussel extract, or placebo, for eight-week periods. Some peak accelerometer activity measures improved versus placebo, while other activity measures did not. Diet and work were not controlled. This does not prove full-fat material outperforms defatted material or that every dog will improve.
Read the study ↗Kang and colleagues
Fifteen dogs with osteoarthritis received a green-lipped mussel oil complex. Pain, orthopaedic and force-plate measures improved at four weeks. There was no placebo group, so the study cannot show how much of that change came from the oil complex rather than time or other care.
Read the paper ↗Dobenecker and colleagues, as summarized in a veterinary review
A placebo-controlled comparison of a mussel extract, chondroitin and placebo did not find a clear improvement in recorded symptoms. Evidence is not uniformly positive.
Read the veterinary evidence review ↗Combination products: useful, but different
Corbee and colleagues
Thirty-two dogs enrolled in a blinded crossover trial of a supplement containing green-lipped mussel, curcumin and blackcurrant leaf. Some owner-rated pain and lameness outcomes improved, but the result cannot be attributed to mussel alone.
Read the trial ↗Kampa and colleagues — mussel lipids and mussel-plus-krill
Seventy-five dogs with hip osteoarthritis were assigned to mussel-derived lipid extract (PCSO-524), mussel-plus-krill extract (EAB-277), glucosamine and chondroitin, carprofen or placebo. At four weeks, both marine extract groups and carprofen showed greater improvement in measured limb loading than placebo. These are concentrated lipid preparations, not whole mussel powder.
Read the trial ↗ · See its correction ↗Kampa and colleagues — a separate 101-dog study
Dogs with hip osteoarthritis received a mussel-plus-krill extract, another supplement, meloxicam or placebo. After six weeks, measured limb loading improved more in the mussel-plus-krill group than placebo. Meloxicam showed a measurable benefit earlier, at two weeks. Neither result establishes the effect of plain mussel powder.
Read the trial ↗Lab work is a different level of evidence
Jhun and colleagues
The study shared with us tested experimentally induced osteoarthritis in rats and examined cell-level mechanisms. It can inform hypotheses about green-lipped mussel, but it is not a canine clinical trial and does not prove that a retail dog product reduces arthritis pain. A 2025 correction added a missing funding acknowledgement; it did not turn this into a dog trial.
Read the original paper ↗ · See the correction ↗So what should an owner conclude?
Some green-lipped mussel preparations have produced encouraging results in dogs with osteoarthritis; other trials do not establish a clear benefit. The evidence supports considering it as an adjunct, not replacing a veterinary plan or claiming a guaranteed result for a different product. See why preparations cannot be compared by milligrams alone.
Explore the full joint supplement comparison